Top 10 Life Science Startup Investors in Austria
A list of 10 angel investors and VC funds that invest in Life science startups based in Austria. We rank investors based on the number of investments they made in Life science companies from Austria. We update this investor list every month.Top 10 Life Science Startup Investors in Austria
Investor | Life Science Austria investments |
---|---|
xista science ventures | 3 |
Nina Capital | 2 |
APEX Ventures | 2 |
Longevitytech.fund | 2 |
R42 Group | 2 |
tecnet equity | 1 |
OrbiMed | 1 |
HCVC | 1 |
Polaris Partners | 1 |
FastVentures | 1 |
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Software
- Seed, Pre-Seed, Series A
- Austria, Slovenia
Portfolio highlights
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- infrared.city — Infrared City is a platform for intelligent and resilient design powered by Artificial Intelligence. We make complex environmental simulations accessible and understandable for all stakeholders of the built environment. Our state-of-the-art machine learning models provide real-time feedback on the performance of design proposals and can guideclimate informed decisions at every step of the process. Infrared City currently provides feedback on solar, sunlight and wind performance. For more information, please visit www.infrared.city
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Austria
Portfolio highlights
- Ryver — We provide software to generate synthetic medical images and assess their privacy as well as quality
- CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
- Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Germany, Austria, United Kingdom
Portfolio highlights
- sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
- Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
- Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
Investing globally in technologies extending healthy lifespans
Show more
Investment focus
- Biotechnology, Health Care, Personal Health
- Seed, Convertible Note, Pre-Seed
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
- MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
- Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Austria
Portfolio highlights
- Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
- KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
- Reservoir Neuroscience — Reservoir Neuroscience is a biopharma company that develops novel therapeutics to repair dysfunctional blood vessels in the brain. Reservoir Neuroscience was founded in 2019 and is based in Emeryville, California.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Series A
- Austria
Portfolio highlights
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Orderlion — Orderlion is aiming to become the gold standard for online ordering of restaurants & hotels from all their suppliers. Orderlion is already available in more than 20 cities in Austria, Germany, the Czech Republic, Switzerland and France with over 1.000 restaurants and hundreds of suppliers.Orderlion was designed for all types of hospitalitybusinesses (café, restaurant, hotel, chain). The order platform combines all suppliers and products in one app and enables customer-specific pricing. With little effort, the entire inventory of restaurants can be recorded and activated for automatic ordering processes. Orderlion counts numerous prominent restaurants among its customers. Orderlion was founded by Stefan Strohmer and Patrick Schubert in 2018 and has its headquarters in Vienna, Austria.
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- Avalo Therapeutics — Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
- Alterome Therapeutics — Transforming the lives of cancer patients, one alteration at a time. Our Mission is to discover precise therapies and inspire hope for individuals affected by cancer.
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.
Show more
Investment focus
- Software, Artificial Intelligence, Hardware
- Seed, Series A, Pre-Seed
- United States, France, United Kingdom
Portfolio highlights
- atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.
- Transmutex SA — Producing clean energy from nuclear waste is the challenge Transmutex is taking on. Based on experimentaly validated science from CERN in Geneva.
- Chiral — Next-generation electronics with nanomaterials
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- United States, Singapore, Ireland
Portfolio highlights
- Freenome — Freenome is a biotechnology company based in South San Francisco that has pioneered the most comprehensive multiomics platform for early cancer detection with a simple blood test.
- Matter Neuroscience — Over millions and millions of years, a collection of reward systems
- Capstan Therapeutics — Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
venture capital
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Series B
- Hungary, South Korea, United States
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
Investors by industry
Health Care
Biotech
Community
Marketplace
FinTech
Impact
Proptech
Media (entertainment)
EdTech
Consumer
Climate
Energy
Hardware
Gaming
Artificial intelligence
Sustainability
Agriculture (agtech)
Venture Capital
Restaurants
Publishing
Beauty
Oil and Gas
Web3
Video Games
Food and Beverage
Clean Energy
Real Estate
Infrastructure
Big Data
Organic Food
Photography
Fashion
Education
B2B
Renewable Energy
Payments
Financial Services
Sporting Goods
Finance
Retail
Medical
Email
Wellness
Social Media
Music
Franchise
Celebrity
Android
Internet
Legal
Google
eSports
Construction
Recruiting
Local
Platforms
Mobile
Travel
Enterprise Software
Fitness
Sports
Mobile Advertising
Social Network
Manufacturing
Cannabis
Digital Media
Facebook
Biotechnology
Hospitality
Art
Automotive
Social Impact
Crowdfunding
Wine And Spirits
Medical Device
Social
Transportation
CleanTech
InsurTech
Mobile Apps
Enterprise
Software
LGBT
Film
Life Science
Theatre
Non Profit
SaaS
Cryptocurrency
Blockchain
Investors by country
Canada
United Kingdom
Ireland
Germany
South Korea
Australia
United States
India
New Zealand
Oceania
Armenia
China
Europe
Indonesia
LATAM
Middle East
Spain
Asia
Japan
South Africa
Qatar
Vietnam
Saudi Arabia
Singapore
Sri Lanka
Brazil
Africa
Czech Republic
Bahrain
Belize
Bermuda
Costa Rica
Belarus
Bulgaria
Denmark
Algeria
Georgia
Gibraltar
Cameroon
Chile
Finland
Estonia
Faroe Islands
Greece
Ethiopia
Ghana
Hungary
Croatia
Egypt
Belgium
Barbados
Ecuador
France
Hong Kong
Kuwait
Israel
Jersey
Kazakhstan
Nicaragua
Philippines
Italy
Mali
Lithuania
Cambodia
Liechtenstein
Kenya
Liberia
Lebanon
Mauritius
Morocco
Malaysia
Norway
Peru
Myanmar
Cayman Islands
Panama
Malta
Mexico
Seychelles
Slovenia
Russian Federation
Rwanda
Serbia
Uzbekistan
Togo
Taiwan
Ukraine
Sierra Leone
Turkey
Tunisia
Thailand
Tajikistan
Poland
Uganda
Zimbabwe
Tanzania
San Marino
Uruguay
Venezuela
Zambia
Senegal
Puerto Rico
Portugal
Sweden
El Salvador
Nigeria
Bahamas
Azerbaijan
Iraq
Iceland
Namibia
United Arab Emirates
Honduras
Isle of Man
Bolivia
Luxembourg
Argentina
Pakistan
Albania
Austria
Bangladesh
Grenada
Jordan
Romania
Cyprus
Latvia
Oman
Colombia
Switzerland
Guatemala
Marshall Islands
Investors in Austria by industry
Social Impact
Transportation
Music
Real Estate
Big Data
Cryptocurrency
Education
Finance
Food and Beverage
Organic Food
Medical
Wellness
Medical Device
Agriculture (agtech)
Internet
Manufacturing
Digital Media
Android
Mobile
Blockchain
Local
Software
Sports
Enterprise Software
eSports
Fitness
Hospitality
Automotive
InsurTech
Travel
Platforms
Recruiting
FinTech
Biotechnology
Consumer
Health Care
EdTech
Energy
Climate
Sustainability
Impact
Marketplace
Proptech
Artificial intelligence
SaaS
Hardware
Gaming
Mobile Apps
Web3
B2B
Life Science
Publishing
Sporting Goods
Biotech
Renewable Energy
Financial Services
Enterprise
Community
Social Media
Media (entertainment)
CleanTech
Construction
Retail
Payments